피임약 시장 규모, 점유율, 성장 분석 : 제품별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Contraceptives Market size was valued at USD 32.55 Billion in 2024 and is poised to grow from USD 34.96 Billion in 2025 to USD 61.89 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global contraceptives market is experiencing notable expansion due to various driving factors. Growing awareness around family planning and a heightened incidence of sexually transmitted infections (STIs) are central to this growth. Additionally, the demand for effective contraceptive methods is on the rise, supported by advancements in technology, including long-acting reversible contraceptives (LARCs) and an expanding array of options. Government initiatives advocating for family planning and reproductive health further enhance this positive landscape. However, the market faces challenges, including social stigma, cultural barriers, and restricted access in some regions. Despite these obstacles, the increasing focus on women's health and the broadening acceptance of contraception as a means of empowerment are poised to significantly bolster the market's future development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segments Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for growth in the contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As people gain more knowledge about the benefits of contraception for managing population growth and enhancing women's health, the demand for contraceptive methods has surged. This trend is further bolstered by government initiatives and programs designed to advocate for family planning. Additionally, various organizations play a significant role in raising awareness about different contraceptive options, thereby fostering a more informed public. This collective effort is driving an increase in market demand and expanding access to reproductive health solutions.

Restraints in the Contraceptives Market

The global contraceptives market faces significant restraints primarily due to cultural and religious barriers that hinder the acceptance and utilization of contraceptive methods in various regions. In certain communities, traditional beliefs and religious doctrines discourage or limit the use of contraceptives, resulting in lower adoption rates among the population. Additionally, inadequate access to contraceptive options, particularly in rural and underserved areas, poses a challenge. Factors such as limited availability, high costs, and insufficient distribution networks can obstruct the effective use of contraceptives, particularly in developing nations. Addressing these cultural and logistical hurdles is essential for promoting greater accessibility to reliable contraception and fostering the market's growth.

Market Trends of the Contraceptives Market

A prominent trend in the global contraceptives market is the surging interest in long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are increasingly favored by women due to their high efficacy and low maintenance requirements, thereby addressing the need for reliable and convenient birth control solutions. The shift towards LARCs is also driven by technology advancements that have introduced more innovative and user-friendly designs, enhancing their appeal. This growing trend underscores a broader movement towards effective, sustainable contraceptive methods, reflecting changing attitudes towards family planning and reproductive health globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2026-2033)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2026-2033)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations